HYFT News & Events

MindWalk announced an advance in its universal influenza program following the identification of a functional constraint that persists across influenza viruses despite continual evolution. MindWalk identified a functional pattern embedded in influenza biology that remains intact beneath surface-level genetic change. When MindWalk examines what does not change, it is not referring to conserved genetic sequences. It refers to preserved biological constraints; the biophysical requirements influenza must satisfy for infection.

MindWalk announced the results of its 2025 annual general meeting. In accordance with the company's majority voting policy, Kamil Isaev, having received approximately 32% of votes in favor and 68% withheld for his re-election, has tendered his resignation to the board. The board has accepted the resignation, effective immediately, and is initiating a search process to fill the vacancy.

MindWalk announced the appointment of industry veteran R. Scott Areglado as CFO, effective October 20. Areglado brings more than 25 years of financial leadership experience across the healthcare, life sciences, and technology sectors. He most recently served as CFO of BrainsWay and before that was CFO at iCAD.

MindWalk announced the appointment of Thomas Lynch as chief business officer, effective October 20. Most recently, Dr. Lynch served as director of technical sales and scientific support at Aldevron.